DOCSLIB.ORG

Attendees Affiliations List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Attenddees' Affiliations at Regenerative Medicine Crossroad in Tokyo (RMCR#1-#10) 360ipJAPAN KK A & E Planning Co., Ltd. A2 Healthcare Corporation abbott Accenture Japan Ltd ADEKA CORPORATION Advanced Cell Technology and Engineering Ltd. Advanced Innovation Development Co.,Ltd. Agenes co ltd AIR LIQUIDE Japan Ltd. Airex co, ltd., AIST Ajinomoto Co., Inc. Albumedix (former Novozymes Biopharma) AMED Aoki International Advisory Inc. API Co., Ltd. Ark Innovation Asahi Glass Co.,Ltd. Asahi KASEI Corporation ASAHI MediCom Asahi Research Center Co. Ltd. Astellas Pharma Inc., 9-Aug Australian Embassy BASF Japna Ltd. BD Japan BD Japan Beyond Next Ventures BIC GROUP Ltd BioAssociates,Inc. BioBeOne Inc. BIOMIMETICS SYMPATHIES Inc. bio-techne Biotherapy Institute of Japan, Inc BNCTbiomedical.Inc Canon INC. Canon Medical Systems Co. Celgene K. K. CellFiber Co., Ltd. Cellgentech Cell Innovation Partners / Shinsei Corporate Investment Cell Sheet Tissue Engineering Regenerative Medicine Initiative CellSeed Inc. Center for Advanced Medical Innovation CHA Medical University CHARTAE Chiba University, Chiome Bioscience, Inc. Chiyoda Corporation Chugai Pharmaceutical Co., Ltd. CJ HealthCare Japan office CJ PARTNERS Inc. Clinipace K. K. Clio, Inc. CMC RESEARCH LTD. CMIC HOLDINGS Co.,Ltd. COSMO Cosmo Bio Co., Ltd. Cosmo Public Relations Corporation 1 Attenddees' Affiliations at Regenerative Medicine Crossroad in Tokyo (RMCR#1-#10) Covance Japan Co., Ltd. Dai Nippon Printing Co.,Ltd. Daiichi Sankyo Co., Ltd. Daiwa Corporate Investment Co., Ltd. Decision Resources Group Japan Branch Dendrix inc. DIC Corporation DMK FOUNDATION DyDo Pharma EA Pharma Co., Ltd. EELS eidacoeida Eight Roads Ventures Japan Eisai.Co.Ltd Embody Science Corp. eppendorf Co., Ltd. EPS Corporation EU-Japan center for industrial cooperation Eurofins Genomics K.K. Evonik Japan Co., Ltd. Explorer Associates Fast Track Initiative, Inc. Formulatrix, Inc. FORESIGHT&LINX Co., Lyd. Foundation for Biomedical Research and Innovation Free & Share Inc French Embassy Frontier Management Inc. FUJI CHEMICALS LTD FUJIFILM corporation FUJIFILM Wako Pure Chemical Corporation FUJITSU LIMITED GE Healthcare Gellycle Co., Ltd Gene Techno Science Co.,Ltd. Gene Therapy Research Institution Co., Ltd. Genesis Inc. genotec Inc. GN Corporation Gotoh physics chemistry industry institute Green Peptide Inc GUNZE LIMITED Hamamatsu Pharma Research, Inc. Hanhoo Cosmetics Co. LTD Healios K.K. herstorys Higeta Shoyu co.,ltd Histogenics Corp. Hitachi Chemical Co., Ltd. Hitachi, Ltd. Hokkaido University Hosei University Human Life CORD Japan Human Metabolome Technologies Inc. i4h Corporation inc. IEDA CHEMICAL CO.,LTD iHeart Japan Corporation Ikeda-Scientific co., Ltd. ImmunisBio Co., Ltd. INABATA & CO.,LTD. 2 Attenddees' Affiliations at Regenerative Medicine Crossroad in Tokyo (RMCR#1-#10) INCJ Inc.Ohbi Infinity Labs KK Institute for Frontier Medical Sciences Kyoto University Integrated Development Associates Co., Ltd. intellim Corporation Intralink KK Itochu Corporation Iwatani Corporation J1 Pharma Consulting Services Janssen Pharmaceutical K.K. Japan Agency for Medical Research and Development Japan Bioindustry Association Japan External Trade Organization (JETRO) Japan Innovative Therapeutics, Inc. Japan Pharmaceutical Industry Association Japan Pharmaceutical Manufacturers Association Japan Research Institute, Limited. Japan Science and Technology Agency Japan Tissue Engineering Co., Ltd. JBM Incorporation JCR Pharmaceuticals Co., Ltd. Johnson & Johnson JSR Corporation Juntendo Tokyo Koto Geriatric Medical Center JX Nippon Oil & Energy Corporation Kanagawa Prefectural Government Kaneka Corp KANEMATSU-RI KANTO CHEMICAL CO., INC. KIHARA MEMORIAL YOKOHAMA FOUNDATION Kintaro Cells Power Co. kirin kishida chemical co. Kissei Pharmaceutical Co., Ltd. KNC Labolatories Co.,Ltd Knoell Japan co.,ltd. kobe city gavernment Koken Co., Ltd. Kou Occupational health Insurance office KSP, Inc. Kyocera Corporation Kyodo International Inc. KYORIN PHARMACEUTICAL CO.,LTD. Kyoritsu Cosmetic Surgery, Dental Kyoto University Kyowa Kirin Co., Ltd Laboratory of Cell Applied Technologies, Co Lasertec Leda Co., Ltd. Leda Group Holdings Co., Ltd. Life Science Institute, Inc. Lonza Japan LPIXEL Inc. LTT-BioPharma Luminex Corporation Japan Luqman Weise Capital Macrobiosis Inc. Managirial Improvement unit manseisya co., ltd 3 Attenddees' Affiliations at Regenerative Medicine Crossroad in Tokyo (RMCR#1-#10) Maria Von Stem Cell Marken Limited Market Developers,Inc Maruho.co., ltd. Matrixome, Inc. McKinsey & Company MD Inc MDL Mebiol Inc. Medical Incubator Japan K.K. MEDINET Co., Ltd. MEDIPAL HOLDINGS CORPORATION Medtronic Japan Co., Ltd. Merck Serono Co., Ltd. merena model production & city production MeSCue Inc. Metcela Inc. Metcela Inc. METI METI Kanto Bureau of Economy, Trade and Industry Micronics Japan Co.LTD Micron, Inc. MII-Reserch-Institute Miltenyi Biotech K.K. Miraca Holdings Inc. MITO KOGYO Mitsubishi Chemical Corporation MITSUBISHI GAS CHEMICAL COMPANY, INC. Mitsubishi Logistics Corporation Mitsubishi Tanabe Pharma Corporation mitsubishi UFJ financial partners MITSUI ＆ CO., LTD. MIZUHO Mizuho Securities MOCHIDA PHARMACEUTICAL CO., LTD. Monocl MORE Medical Inc. MOROO CO.,LTD MTI Ltd. MUFG Bank Mutoh Corporation NAGANOSCIENCE Nagoya Industrial Science Research Institute Nagoya Institute for Scientific Research Innovation Nanofoto National Agency for Automotive Safety and Victims' Aid National Institute of Advanced Industrial Science and Rechnology New England Biolabs Japan, Inc. New Industry Research Organization Nexredge Inc. Nichi-in Centre for Regenerative Medicine (NCRM), India NIHON KOHDEN CORPORATION Nihon Pharmaceutical co., ltd. Nihon University School of Medicine nikkei Business Publications NIKON Cell Innovation Co., Ltd. Nikon Corporation Nil Nippi Nippon Becton Dickinson Company, Ltd. 4 Attenddees' Affiliations at Regenerative Medicine Crossroad in Tokyo (RMCR#1-#10) NIPPON EXPRESS Nippon Pillar Packing Co.,Ltd. Nippon Shinyaku Co., Ltd. Nipro Corporation Nobelpharma Co., Ltd. NOF CORPORATION NOMURA UNISON CO.,LTD North American Science Associates, Inc. (NAMSA) Novartis Pharma K.K. Novumcella Inc. NRW Japan K.K NTT DATA INSTITUTE OF MANAGEMENT CONSULTING, Inc. Oda clinic Office YANAGIDA Oncolys Biopharma Inc. OPTIMA INC. Orphanpacific.inc OSAKA SANITARY CO., LTD Osteopharma Inc. Otsuka Holdings Co., Ltd. Otsuka Pharmaceutical Co., Ltd. Otsuka Pharmaceutical Factory,Inc. Otsuka Techno Corporation Pfizer Inc. Pfizer Japan Phacilitate PharmaBio Corporation Pharmacological Evaluation Institute of Japan PHC Corporation Phoenix Company Piny (Beijing) Business Consulting Co., Ltd. PMDA POC Clinical Research Inc. PortmanRoadJP Co., Ltd. PuREC.,Co,Ltd. PURPOSE CO., LTD. PwC Consulting inc. Regience K.K. Repertoire Genesis, Inc. ReproCell Company RIKEN Riken Genesis Co., Ltd. Rin Institute Inc. Roche Diagnostics K.K. ROHTO PHARMACEUTICAL SanBio Company Limited Sanofi S.A. Santen Pharmaceutical Co., Ltd Satoru GK SBI investment SBI Pharmaceuticals Co., Ltd. SCREEN Holdings Co., Ltd. Scrum Inc. Seikagaku Corporation SEKISUI CHEMICAL CO., LTD. Sekisui Medical Co., Ltd. Shimadzu Corporation Senior Expert Forum Shin Nippon Biomedical Laboratories, Ltd. Shionogi & Co., Ltd. 5 Attenddees' Affiliations at Regenerative Medicine Crossroad in Tokyo (RMCR#1-#10) SHISEIDO CO., LTD Showa Yakuhin Kako Co., Ltd. SINFONIA TECHNOLOGY CO., LTD. SMRJ SoftBank Group Corp Sophia Hill Venture Partners, Inc Sosei CVC Ltd. Soukenkanri Co.,Ltd. SRD Co., Ltd. SRL, Inc. Stemcell Steminent Biotherapeutics, Inc. Sumika Chemical Analysis Service, Ltd. Sumitomo Dainippon Pharma Co.Ltd. SUMITOMO MITSUI BANKING CORPORATION Summit Pharmaceuticals International corporation SunFlare Co., Ltd. SUNMEDIX CORPORATION SUZUKEN Sysmex TA Instruments Japan Inc. Taisho pharmaceutical company Taiwan Research-based Biopharmaceutical Manufacturers Association T&R Biofab Co. Ltd. Takara Bio Inc. Takeda Pharmaceutical Company Limited TEC Project Services Teijin Ltd Teijin Pharma Limited TERUMO BCT TERUMO Corporation Tesu Collaboartion TEVA Pharmaceutical K.K. TEXCELL JAPAN KK The New Industry Research Organization ThinkCyte Inc TIR Research Consuthing LLC TNAX Biopharma Corporation Toagosei Co., Ltd. Tokyo Electron Europe Limited Tokyo Electron Limited Tokyo Mobile-Multimedia Laboratory TOKYO PHARMACEUTICAL Co., Ltd. Tokyo Stock Exchang .inc Toppan Printing Toray Industries,Inc. Toray Research Center, Inc. Tosoh Corporation Toyota Tsusho Corporation Transperfect Tsuji SME Business Consulting Office TX Entrepreneur Partners UK Trade & Investment ULVAC COATING CORPORATION Universal Bank, Inc. University of Central Florida College of Medicine/PROGENICYTE LCC. University of Tokyo Edge Capital University of Utah University of Yamanashi UTokyo Innovation Platform Co., Ltd. 6 Attenddees' Affiliations at Regenerative Medicine Crossroad in Tokyo (RMCR#1-#10) Wanbishi Archives Co.,Ltd. Waseda University YAKUKENSHA CO LTD Yamato Scientific Co,.Ltd. YASUI ARCHITECTS & ENGINEERS,INC. Yokogawa Electric Corporation Yonezawa Hamari Chemicals, ltd. Yoshida Dental Mfg. Co., Ltd. Y'S corporation ZERIA Pharmaceutical Co., Ltd Zimmer Biomet G.K 7.
Recommended publications
  • Nilotinib in Patients with Chronic Myeloid Leukemia: STAT2 Trial in Japan

    Nilotinib in Patients with Chronic Myeloid Leukemia: STAT2 Trial in Japan

    Haematologica HAEMATOL/2018/194894 Version 3 Haematologica HAEMATOL/2018/194894 Version 3 Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan Naoto Takahashi, Kaichi Nishiwaki, Chiaki Nakaseko, Nobuyuki Aotsuka, Koji Sano, Chikako Ohwada, Jun Kuroki, Hideo Kimura, Michihide Tokuhira, Kinuko Mitani, Kazuhisa Fujikawa, Osamu Iwase, Kohshi Ohishi, Fumihiko Kimura, Tetsuya Fukuda, Sakae Tanosaki, Saori Takahashi, Yoshihiro Kameoka, Hiroyoshi Nishikawa, and Hisashi Wakita Disclosures: 1. This study was supported by research funding from Novartis Pharmaceuticals to N.T. 2. N.T reports grants from Novartis Pharmaceuticals, during the conduct of the study; grants and personal fees from Novartis Pharmaceuticals, grants and personal fees from Otsuka, grants and personal fees from Pfizer, personal fees from Bristol-Myers Squibb, outside the submitted work; K.N reports grants from Zenyaku Kogyo Company, Limited, grants from Chugai Pharmaceutical, grants from Novartis Pharma K.K., grants from Kyowa Hakko Kirin Co, Ltd, grants from Nippon Shinyaku Co, Ltd, outside the submitted work; C.N reports personal fees from Novartis, grants and personal fees from Bristol-Myers Squibb, grants and personal fees from Pfizer, grants and personal fees from Takeda pharmaceuticals, grants and personal fees from Kyowa Hakko Kirin, grants and personal fees from Otsuka Pharmaceutical, grants and personal fees from Ono Pharmaceutical, grants and personal fees from Chugai Pharmaceutical, grants and personal fees from Asahi Kasei Pharma, grants and personal fees from Shionogi, personal fees from Shire, personal fees from Jannsen, personal fees from Celgene, outside the submitted work; M.T. reports personal fees from Bristol-Myers Squib, personal fees from Pfizer, outside the submitted work; K.M reports grants from Kyowa Hakko Kirin Co.
  • OCTOBER 2020 PTAB Public Hearing Schedule

    OCTOBER 2020 PTAB Public Hearing Schedule

    OCTOBER 2020 PTAB Public Hearing Schedule Proceeding No. Serial No. PARTY Date Time 2020-004197 16043641 BIOGEN MA INC Thursday, October 1, 2020 9:00 AM (EDT) ALLERGAN PHARMACEUTICALS 2020-002635 13907447 Thursday, October 1, 2020 9:00 AM (EDT) INTERNATIONAL LIMITED 2020-002276 13612925 BAYER AG (MONSANTO) Thursday, October 1, 2020 9:00 AM (EDT) 2020-002277 13612929 OTSUKA PHARMACEUTICAL CO., 2020-002304 14341306 Thursday, October 1, 2020 9:00 AM (EDT) LTD. 2020-002327 15893354 CELLECTIS Thursday, October 1, 2020 9:00 AM (EDT) 2020-000258 15163285 POLY GROUP LLC Thursday, October 1, 2020 9:00 AM (PDT) 2020-000640 15414456 DISCERNDX INC. Thursday, October 1, 2020 9:00 AM (PDT) 2020-000934 13982470 DENOVO BIOMARKERS INC. Thursday, October 1, 2020 9:00 AM (PDT) THE BOARD OF TRUSTEES OF THE 2020-001247 15175848 LELAND STANFORD JUNIOR Thursday, October 1, 2020 9:00 AM (PDT) UNIVERSITY EDWARDS LIFESCIENCES 2020-001487 14563866 Thursday, October 1, 2020 9:00 AM (PDT) CORPORATION IKEDA FOOD RESEARCH COL LTD 2020-003630 16145178 Thursday, October 1, 2020 1:00 PM (EDT) and PHC CORPORATION 2020-002049 13310632 ADARE PHARMACEUTICALS INC. Thursday, October 1, 2020 1:00 PM (EDT) 2020-000053 13135898 OLEG ILLICH EPSHTEIN Thursday, October 1, 2020 1:00 PM (EDT) 2020-001829 15008646 MERZ PHARMA GMBH & CO. KGAA Thursday, October 1, 2020 1:00 PM (EDT) 2020-002360 15407037 IONIS PHARMACEUTICALS INC. Thursday, October 1, 2020 1:00 PM (EDT) 2020-002113 13729631 L'OREAL Thursday, October 1, 2020 1:00 PM (EDT) 2019-003658 13576565 QUNZHU LI and LI LI Thursday, October 1, 2020 1:00 PM (EDT) 2020-000322 14136660 CYTEC INDUSTRIES INC.
  • Toyota Tsusho Corporation Financial Highlights for the Three Months Ended June 30, 2020 [IFRS Basis] (Consolidated) July 31, 2020

    Toyota Tsusho Corporation Financial Highlights for the Three Months Ended June 30, 2020 [IFRS Basis] (Consolidated) July 31, 2020

    Toyota Tsusho Corporation Financial Highlights for the Three Months Ended June 30, 2020 [IFRS basis] (Consolidated) July 31, 2020 Listings Tokyo Stock Exchange (the first section), Nagoya Stock Exchange Security code 8015 URL https://www.toyota-tsusho.com/english/ Representative Ichiro Kashitani, President & CEO Contact Yasushi Aida General manager, Accounting Department Telephone +81 52-584-5482 Scheduled dates: Submission of quarterly securities report August 13, 2020 Dividend payout - Supplementary materials to the quarterly results Available Quarterly financial results briefings Yes (targeted at institutional investors and analysts) (Amounts rounded down to the nearest million yen) 1. Consolidated Financial Results for the Three Months ended June 30, 2020 (April 1, 2020 to June 30, 2020) (1) Operating Results (Percentage figures represent year-on-year changes) Total Profit before Profit attributable to Revenue Operating profit Profit comprehensive income taxes owners of the parent income Three Months ended million yen % million yen % million yen % million yen % million yen % million yen % June 30, 2020 1,193,982 (29.3) 19,139 (65.6) 25,995 (68.1) 16,386 (73.6) 13,393 (75.9) 35,159 (5.1) June 30, 2019 1,689,853 2.4 55,659 (1.5) 81,561 18.7 62,154 16.4 55,612 19.2 37,048 264.6 Diluted earnings per Basic earnings per share share Three Months ended yen yen June 30, 2020 38.07 － June 30, 2019 158.05 － Note: “Basic earnings per share” is calculated based on “Profit attributable to owners of the parent.” (2) Financial Position Equity attributable to Ratio of equity attributable to owners Total assets Total equity owners of the parent of the parent to total assets As of million yen million yen million yen % June 30, 2020 4,588,118 1,381,773 1,211,544 26.4 March 31, 2020 4,545,210 1,372,491 1,196,635 26.3 2.
  • Published on July 21, 2021 1. Changes in Constituents 2

    Published on July 21, 2021 1. Changes in Constituents 2

    Results of the Periodic Review and Component Stocks of Tokyo Stock Exchange Dividend Focus 100 Index (Effective July 30, 2021） Published on July 21, 2021 1. Changes in Constituents Addition（18） Deletion（18） CodeName Code Name 1414SHO-BOND Holdings Co.,Ltd. 1801 TAISEI CORPORATION 2154BeNext-Yumeshin Group Co. 1802 OBAYASHI CORPORATION 3191JOYFUL HONDA CO.,LTD. 1812 KAJIMA CORPORATION 4452Kao Corporation 2502 Asahi Group Holdings,Ltd. 5401NIPPON STEEL CORPORATION 4004 Showa Denko K.K. 5713Sumitomo Metal Mining Co.,Ltd. 4183 Mitsui Chemicals,Inc. 5802Sumitomo Electric Industries,Ltd. 4204 Sekisui Chemical Co.,Ltd. 5851RYOBI LIMITED 4324 DENTSU GROUP INC. 6028TechnoPro Holdings,Inc. 4768 OTSUKA CORPORATION 6502TOSHIBA CORPORATION 4927 POLA ORBIS HOLDINGS INC. 6503Mitsubishi Electric Corporation 5105 Toyo Tire Corporation 6988NITTO DENKO CORPORATION 5301 TOKAI CARBON CO.,LTD. 7011Mitsubishi Heavy Industries,Ltd. 6269 MODEC,INC. 7202ISUZU MOTORS LIMITED 6448 BROTHER INDUSTRIES,LTD. 7267HONDA MOTOR CO.,LTD. 6501 Hitachi,Ltd. 7956PIGEON CORPORATION 7270 SUBARU CORPORATION 9062NIPPON EXPRESS CO.,LTD. 8015 TOYOTA TSUSHO CORPORATION 9101Nippon Yusen Kabushiki Kaisha 8473 SBI Holdings,Inc. 2.Dividend yield (estimated) 3.50% 3. Constituent Issues (sort by local code) No. local code name 1 1414 SHO-BOND Holdings Co.,Ltd. 2 1605 INPEX CORPORATION 3 1878 DAITO TRUST CONSTRUCTION CO.,LTD. 4 1911 Sumitomo Forestry Co.,Ltd. 5 1925 DAIWA HOUSE INDUSTRY CO.,LTD. 6 1954 Nippon Koei Co.,Ltd. 7 2154 BeNext-Yumeshin Group Co. 8 2503 Kirin Holdings Company,Limited 9 2579 Coca-Cola Bottlers Japan Holdings Inc. 10 2914 JAPAN TOBACCO INC. 11 3003 Hulic Co.,Ltd. 12 3105 Nisshinbo Holdings Inc. 13 3191 JOYFUL HONDA CO.,LTD.
  • Integrated Report 2016 Report for the Next 10 Years, the Toyota Tsusho Group Group Tsusho Toyota for the Next 10 Years, the Will Evoke Our Ideal As “Be the Right ONE”

    Integrated Report 2016 Report for the Next 10 Years, the Toyota Tsusho Group Group Tsusho Toyota for the Next 10 Years, the Will Evoke Our Ideal As “Be the Right ONE”

    TOYOTA TSUSHO CORPORATION Integrated Report 2016 Fiscal year ended March 31, 2016 INTEGRATED REPORT 2016 REPORT INTEGRATED Next Steps for New Growth Competitive Edge in Business For the next 10 years, the Toyota Tsusho Group will evoke our ideal as “Be the Right ONE” Stakeholder Dialogue Editorial Policy Until now, Toyota Tsusho has published an Annual Report, which mainly covers report- ing focused on financial information, management strategies, performance and business activities, and a CSR Report, which mainly covers reporting focused on society and the environment. These two reports were published to deepen the understanding of Toyota Tsusho’s activities among all stakeholders. However, considering that both reports are closely related to one another and our goal of fostering an even stronger understanding of Toyota Tsusho among our stakeholders, we have started producing an Integrated Report from the fiscal year ended March 2015. In the preparation of this report, we have referred to the International Integrated Reporting Framework (International <IR> Framework) advo- cated by the International Integrated Reporting Council (IIRC), the Sustainability Reporting Guidelines (version 4.0) of the Global Reporting Initiative (GRI), the Environmental Reporting Guidelines (2012 version) of the Ministry of the Environment in Japan and the ISO 26000 Guidance on Social Responsibility. In addition to reporting on management strategies, our performance, and business activities, the Integrated Report covers subjects such as Toyota Tsusho’s Approach to CSR, which guides our efforts to resolve social issues and contribute locally through our business activities. As Toyota Tsusho endeavors to drive sustained growth in these and other ways, we hope that this report will help to deepen your understanding of the company.
  • Non Project Grant Aid / Economic and Social Development Programmes

    Non Project Grant Aid / Economic and Social Development Programmes

    Non Project Grant Aid / Economic and Social Development Programmes Contract Award As of 30 September 2020 Tender Fiscal Contract Description of Goods / Services Beneficiary Supplier Issue Date Ref No. Year Value LKN19/108644D/0001 2019 Anti-terrorism equipment (Lot 1,2,4) Sri Lanka Toyota Tsusho Corporation JPY 385,837,500 2020/09/23 MVN19X/108651D/ 0001 2019 Anti-terrorism equipment (Lot 4) Maldives Kanematsu Corporation JPY 104,441,000 2020/09/25 MVN19X/108651D/ 0001 2019 Anti-terrorism equipment (Lot 2&3) Maldives Toyota Tsusho Corporation JPY 188,188,400 2020/09/14 MVN19X/108651D/ 0001 2019 Anti-terrorism equipment (Lot 1) Maldives NBK Corporation JPY 39,950,000 2020/09/14 ZMN19/109005D/0001 2019 Health Centre Kit Zambia Toyota Tsusho Corporation JPY 282,000,000 2020/08/27 BWN20/109742D/0001 2020 Thermography system Botswana NEC Corpration JPY 22,023,080 2020/08/26 BWN20/109742D/0001 2020 Infusion pump/Syringe pump Botswana Nissei Trading JPY 39,800,000 2020/08/26 BWN20/109742D/0001 2020 AED Botswana Marubebi Protechs Corporation JPY 9,720,000 2020/08/26 LKN19/108644D/0001 2019 Minibus Sri Lanka Toyota Tsusho Corporation JPY 26,151,600 2020/07/31 MWN16/106162D/0001 2016 Acrylic Yarn Blend Malawi Sirius Corporation JPY 52,900,000 2020/07/22 MGN15/11711/101-1 2015 Motor Madagascar Parlym International EUR 118,772.00 2020/04/22 Cybersecurity equipment and associated ZWN18/107903D/0001 2018 services (Lot 1&2) Zimbabwe Toyota Tsusho Corporation JPY 366,600,000 2020/01/06 Futurebud International Co., XKN18/107902D/0001 2018 Compactor Trucks and Associated Services Kosovo Ltd.
  • OSB Participant List by Research Area

    OSB Participant List by Research Area

    OSB Participant List by Research Area Contact Centers (CC) • AARP • Air Products and • American Drug Stores Chemicals • AAA • ABB • American Electric Power • Airbus • Accor • Abbott • American Express • Alcatel Lucent • American Electric Power • Abengoa • American International • Alcoa Group • American International • Abu Dhabi National Group Energy Company • Alcon • American Stores Company • Austin Energy • ACC Limited • Alfa • American Water • Bank of America • Access Insurance Holdings • Algonquin Power & • Amgen Utilities • Blue Cross Blue Shield • Accord Holdings • AMIL • ALH Group • Charles Schwab & • ACE • AmInvestment Bank Company • Alitalia • Acea • AMR • Citigroup • ALK Abello • Acer • Amssi • Citizens Gas • Alkermes • Acxiom • Amtran Logistics • Clarke American • Allergan • Adelaide Clinic Holdings • Andrew Corporation • CPS Energy • Alliance & Leicester • Adidas • Anglian Water Services • Direct Energy • Alliance Boots • Advance Food Company • Anritsu • Federal Reserve Bank of • Alliant Techsystems Minneapolis • Advance Publications • Anschutz • Allianz • John Deere • Advanced Coating • Apache • Allied Irish Banks • Technologies Louisville Water Company • Apex Equity Holdings • Advanced Semiconductor • Allstate Insurance • Manila Electric Company Engineering Company • Apple • • • Mellon Financial Adventist Health System Ally Financial • Arcadia Housing • • • MetLife Aegon Alon USA Energy • Arcos Dorados Holdings • • • Morgan Stanley AEON AlpTransit Gotthard • Ardent Health Services • • • NetBank Aera Energy Alstom • Argos •
  • ANNUAL REPORT FY2014 for the Year Ended March 31, 2015 Courtesy of Mizushima LNG Co., Ltd

    ANNUAL REPORT FY2014 for the Year Ended March 31, 2015 Courtesy of Mizushima LNG Co., Ltd

    ANNUAL REPORT FY2014 For the year ended March 31, 2015 Courtesy of Mizushima LNG Co., Ltd. Financial Highlights Years Ended March 31, 2015, 2014, 2013, 2012, and 2011 2015 2014 2013 2012 2011 For the Year (Millions of Yen) Revenues ¥480,979 ¥446,147 ¥398,918 ¥254,675 ¥247,082 Cost of revenue 435,327 404,685 356,402 215,783 215,563 Operating income 21,466 21,079 25,113 24,197 17,544 Income before income taxes and minority interests 22,012 22,538 26,747 23,543 11,476 Net income 11,029 13,447 16,077 14,364 7,979 At Year-End (Millions of Yen) Total assets ¥515,839 ¥475,288 ¥435,379 ¥365,795 ¥353,392 Profile Total equity 208,405 198,031 189,356 168,737 155,758 Current ratio (%) 151.0 156.3 166.3 165.5 173.8 Founded in 1948 in the post war period to reconstruct Japan, Chiyoda started its engi- Per Common Share (Yen) neering business for domestic projects mainly in petroleum refining, gas processing and Earnings per share (EPS) ¥42.58 ¥51.91 ¥62.06 ¥55.44 ¥30.79 petrochemical fields, and expanded into overseas projects in the 1960s. Since then, Chiyoda Book value per share (BPS) 796.89 758.31 727.24 648.95 599.15 has been and is growing steadily under the corporate philosophy of enhancing its business by aiming for harmony between energy and the environment and contributing to the Dividend per share 13.0 16.0 19.0 17.0 11.0 sustainable development of society.
  • FTSE Japan ESG Low Carbon Select

    FTSE Japan ESG Low Carbon Select

    2 FTSE Russell Publications 19 August 2021 FTSE Japan ESG Low Carbon Select Indicative Index Weight Data as at Closing on 30 June 2021 Constituent Index weight (%) Country Constituent Index weight (%) Country Constituent Index weight (%) Country ABC-Mart 0.01 JAPAN Ebara 0.17 JAPAN JFE Holdings 0.04 JAPAN Acom 0.02 JAPAN Eisai 1.03 JAPAN JGC Corp 0.02 JAPAN Activia Properties 0.01 JAPAN Eneos Holdings 0.05 JAPAN JSR Corp 0.11 JAPAN Advance Residence Investment 0.01 JAPAN Ezaki Glico 0.01 JAPAN JTEKT 0.07 JAPAN Advantest Corp 0.53 JAPAN Fancl Corp 0.03 JAPAN Justsystems 0.01 JAPAN Aeon 0.61 JAPAN Fanuc 0.87 JAPAN Kagome 0.02 JAPAN AEON Financial Service 0.01 JAPAN Fast Retailing 3.13 JAPAN Kajima Corp 0.1 JAPAN Aeon Mall 0.01 JAPAN FP Corporation 0.04 JAPAN Kakaku.com Inc. 0.05 JAPAN AGC 0.06 JAPAN Fuji Electric 0.18 JAPAN Kaken Pharmaceutical 0.01 JAPAN Aica Kogyo 0.07 JAPAN Fuji Oil Holdings 0.01 JAPAN Kamigumi 0.01 JAPAN Ain Pharmaciez <0.005 JAPAN FUJIFILM Holdings 1.05 JAPAN Kaneka Corp 0.01 JAPAN Air Water 0.01 JAPAN Fujitsu 2.04 JAPAN Kansai Paint 0.05 JAPAN Aisin Seiki Co 0.31 JAPAN Fujitsu General 0.01 JAPAN Kao 1.38 JAPAN Ajinomoto Co 0.27 JAPAN Fukuoka Financial Group 0.01 JAPAN KDDI Corp 2.22 JAPAN Alfresa Holdings 0.01 JAPAN Fukuyama Transporting 0.01 JAPAN Keihan Holdings 0.02 JAPAN Alps Alpine 0.04 JAPAN Furukawa Electric 0.03 JAPAN Keikyu Corporation 0.02 JAPAN Amada 0.01 JAPAN Fuyo General Lease 0.08 JAPAN Keio Corp 0.04 JAPAN Amano Corp 0.01 JAPAN GLP J-REIT 0.02 JAPAN Keisei Electric Railway 0.03 JAPAN ANA Holdings 0.02 JAPAN GMO Internet 0.01 JAPAN Kenedix Office Investment Corporation 0.01 JAPAN Anritsu 0.15 JAPAN GMO Payment Gateway 0.01 JAPAN KEWPIE Corporation 0.03 JAPAN Aozora Bank 0.02 JAPAN Goldwin 0.01 JAPAN Keyence Corp 0.42 JAPAN As One 0.01 JAPAN GS Yuasa Corp 0.03 JAPAN Kikkoman 0.25 JAPAN Asahi Group Holdings 0.5 JAPAN GungHo Online Entertainment 0.01 JAPAN Kinden <0.005 JAPAN Asahi Intecc 0.01 JAPAN Gunma Bank 0.01 JAPAN Kintetsu 0.03 JAPAN Asahi Kasei Corporation 0.26 JAPAN H.U.
  • Factset-Top Ten-0521.Xlsm

    Factset-Top Ten-0521.Xlsm

    Pax International Sustainable Economy Fund USD 7/31/2021 Port. Ending Market Value Portfolio Weight ASML Holding NV 34,391,879.94 4.3 Roche Holding Ltd 28,162,840.25 3.5 Novo Nordisk A/S Class B 17,719,993.74 2.2 SAP SE 17,154,858.23 2.1 AstraZeneca PLC 15,759,939.73 2.0 Unilever PLC 13,234,315.16 1.7 Commonwealth Bank of Australia 13,046,820.57 1.6 L'Oreal SA 10,415,009.32 1.3 Schneider Electric SE 10,269,506.68 1.3 GlaxoSmithKline plc 9,942,271.59 1.2 Allianz SE 9,890,811.85 1.2 Hong Kong Exchanges & Clearing Ltd. 9,477,680.83 1.2 Lonza Group AG 9,369,993.95 1.2 RELX PLC 9,269,729.12 1.2 BNP Paribas SA Class A 8,824,299.39 1.1 Takeda Pharmaceutical Co. Ltd. 8,557,780.88 1.1 Air Liquide SA 8,445,618.28 1.1 KDDI Corporation 7,560,223.63 0.9 Recruit Holdings Co., Ltd. 7,424,282.72 0.9 HOYA CORPORATION 7,295,471.27 0.9 ABB Ltd. 7,293,350.84 0.9 BASF SE 7,257,816.71 0.9 Tokyo Electron Ltd. 7,049,583.59 0.9 Munich Reinsurance Company 7,019,776.96 0.9 ASSA ABLOY AB Class B 6,982,707.69 0.9 Vestas Wind Systems A/S 6,965,518.08 0.9 Merck KGaA 6,868,081.50 0.9 Iberdrola SA 6,581,084.07 0.8 Compagnie Generale des Etablissements Michelin SCA 6,555,056.14 0.8 Straumann Holding AG 6,480,282.66 0.8 Atlas Copco AB Class B 6,194,910.19 0.8 Deutsche Boerse AG 6,186,305.10 0.8 UPM-Kymmene Oyj 5,956,283.07 0.7 Deutsche Post AG 5,851,177.11 0.7 Enel SpA 5,808,234.13 0.7 AXA SA 5,790,969.55 0.7 Nintendo Co., Ltd.
  • CORPORATE DIRECTORY (As of June 28, 2000)

    CORPORATE DIRECTORY (As of June 28, 2000)

    CORPORATE DIRECTORY (as of June 28, 2000) JAPAN TOKYO ELECTRON KYUSHU LIMITED TOKYO ELECTRON FE LIMITED Saga Plant 30-7 Sumiyoshi-cho 2-chome TOKYO ELECTRON LIMITED 1375-41 Nishi-Shinmachi Fuchu City, Tokyo 183-8705 World Headquarters Tosu City, Saga 841-0074 Tel: 042-333-8411 TBS Broadcast Center Tel: 0942-81-1800 District Offices 3-6 Akasaka 5-chome, Minato-ku, Tokyo 107-8481 Kumamoto Plant Osaka, Kumamoto, Iwate, Tsuruoka, Sendai, Tel: 03-5561-7000 2655 Tsukure, Kikuyo-machi Aizuwakamatsu, Takasaki, Mito, Nirasaki, Toyama, Fax: 03-5561-7400 Kikuchi-gun, Kumamoto 869-1197 Kuwana, Fukuyama, Higashi-Hiroshima, Saijo, Oita, URL: http://www.tel.co.jp/tel-e/ Tel: 096-292-3111 Nagasaki, Kikuyo, Kagoshima Regional Offices Ozu Plant Fuchu Technology Center, Osaka Branch Office, 272-4 Takaono, Ozu-machi TOKYO ELECTRON DEVICE LIMITED Kyushu Branch Office, Tohoku Regional Office, Kikuchi-gun, Kumamoto 869-1232 1 Higashikata-cho, Tsuzuki-ku Yamanashi Regional Office, Central Research Tel: 096-292-1600 Yokohama City, Kanagawa 224-0045 Laboratory/Process Technology Center Koshi Plant Tel: 045-474-7000 Sales Offices 1-1 Fukuhara, Koshi-machi Sales Offices Sendai, Nagoya Kikuchi-gun, Kumamoto 861-1116 Utsunomiya, Mito, Kumagaya, Kanda, Tachikawa, Tel: 096-349-5500 Yamanashi, Matsumoto, Nagoya, Osaka, Fukuoka TOKYO ELECTRON TOHOKU LIMITED Tohoku Plant TOKYO ELECTRON MIYAGI LIMITED TOKYO ELECTRON LEASING CO., LTD. 52 Matsunagane, Iwayado 1-1 Nekohazama, Nemawari, Matsushima-machi 30-7 Sumiyoshi-cho 2-chome Esashi City, Iwate 023-1101 Miyagi-gun, Miyagi
  • Mizuho BK Custody and Proxy Board Lot Size List OCT 27, 2020 21LADY

    Mizuho BK Custody and Proxy Board Lot Size List OCT 27, 2020 21LADY

    Mizuho BK Custody and Proxy Board Lot Size List OCT 27, 2020 Board Lot Stock Name (in Alphabetical Order) ＩＳＩＮ Code ＱＵＩＣＫ Code Size 21LADY CO.,LTD. 100 JP3560550000 3346 3-D MATRIX,LTD. 100 JP3410730000 7777 4CS HOLDINGS CO.,LTD. 100 JP3163300001 3726 A DOT CO.,LTD 100 JP3160590000 7063 A-ONE SEIMITSU INC. 100 JP3160660001 6156 A.D.WORKS GROUP CO.,LTD. 100 JP3160560003 2982 A&A MATERIAL CORPORATION 100 JP3119800005 5391 A&D COMPANY,LIMITED 100 JP3160130005 7745 A&T CORPORATION 100 JP3160680009 6722 ABALANCE CORPORATION 100 JP3969530009 3856 ABC-MART,INC. 100 JP3152740001 2670 ABHOTEL CO.,LTD. 100 JP3160610006 6565 ABIST CO.,LTD. 100 JP3122480001 6087 ACCESS CO.,LTD. 100 JP3108060009 4813 ACCESS GROUP HOLDINGS CO.,LTD. 100 JP3108190004 7042 ACCRETE INC. 100 JP3108180005 4395 ACHILLES CORPORATION 100 JP3108000005 5142 ACMOS INC. 100 JP3108100003 6888 ACOM CO.,LTD. 100 JP3108600002 8572 ACRODEA,INC. 100 JP3108120001 3823 ACTCALL INC. 100 JP3108140009 6064 ACTIVIA PROPERTIES INC. 1 JP3047490002 3279 AD-SOL NISSIN CORPORATION 100 JP3122030004 3837 ADASTRIA CO.,LTD. 100 JP3856000009 2685 ADEKA CORPORATION 100 JP3114800000 4401 ADISH CO.,LTD. 100 JP3121500007 7093 ADJUVANT COSME JAPAN CO.,LTD. 100 JP3119620007 4929 ADTEC PLASMA TECHNOLOGY CO.,LTD. 100 JP3122010006 6668 ADVAN CO.,LTD. 100 JP3121950004 7463 ADVANCE CREATE CO.,LTD. 100 JP3122100005 8798 ADVANCE RESIDENCE INVESTMENT CORPORATION 1 JP3047160001 3269 ADVANCED MEDIA,INC. 100 JP3122150000 3773 ADVANEX INC. 100 JP3213400009 5998 ADVANTAGE RISK MANAGEMENT CO.,LTD. 100 JP3122410008 8769 ADVANTEST CORPORATION 100 JP3122400009 6857 ADVENTURE,INC. 100 JP3122380003 6030 ADWAYS INC. 100 JP3121970002 2489 AEON CO.,LTD. 100 JP3388200002 8267 AEON DELIGHT CO.,LTD.